TFAM and neurodegenerative disease: TFAM protein levels in the CNS were shown to be reduced by ~43% in some AD, PD, and HD patients, demonstrating the association of TFAM abnormalities with a variety of neurodegenerative diseases (Sheng et al., 2012; Kang et al., 2018).